Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.

Author(s): Isakbaeva E, Musabaevc E, Antil L, et al.

Published: 2007

Resource types: Peer-reviewed journal

Diseases: Rotavirus

Topics: Immunization financing; Disease/vaccine specific information

Regions: Eastern Europe